ContinuumRx
ContinuumRx is a Birmingham-based home and alternate-site infusion therapy and specialty pharmacy provider that delivers IV antibiotics, TPN, IVIG, heart failure, and biologic therapies to patients across 14 southeastern and mid-Atlantic U.S. states through hospital partnerships, home visits, and six infusion centers.
- Company typePrivate
- Founded2003
- HeadquartersBirmingham, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What ContinuumRx does
ContinuumRx is a private home and alternate-site infusion therapy and specialty pharmacy provider founded in 2001 and headquartered in Birmingham, Alabama. The company administers a portfolio of clinical services — antibiotic therapy, enteral nutrition, total parenteral nutrition (TPN), IVIG, heart failure therapy (including inotropes such as milrinone and dobutamine), and biologic therapies — delivered either directly to patient homes or through six physical infusion centers located in Alabama, Tennessee, Virginia, and Ohio. Underlying technology is clinical rather than software: pharmacy compounding operations, sterile IV preparation, durable medical equipment provision, and 24/7 on-call pharmacy and delivery coverage, supported by ACHC and PCAB accreditation and a digital portal of specialty medication referral forms.
The company monetizes primarily through insurance reimbursement (commercial carriers, Medicare Part B covering ~80% of therapy cost, and Medicaid), with commercial home infusion rates running 40–60% below hospital-based equivalents and saving an estimated $1,928–$2,974 per treatment course. Its go-to-market is sales-led and partnership-driven, anchored by 40+ hospital and health system referral relationships — including Ascension, UAB Medicine, Inova, Erlanger, Huntsville Hospital, and the University of Tennessee Medical Center — supplemented by physician referrals, a coordinated discharge workflow, and a wholly-owned subsidiary (Continuum Health) that operates spa-like infusion facilities. The company operates as a subsidiary of Acelpa Health following a 2024 consolidation, led by CEO Keith P. Hartman, and serves patients across 14 southeastern and mid-Atlantic U.S. states.
ContinuumRx firmographics
Firmographics- Name
- ContinuumRx
- Legal name
- ContinuumRx
- Website
- https://continuumrx.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ContinuumRx is a Birmingham-based home and alternate-site infusion therapy and specialty pharmacy provider that delivers IV antibiotics, TPN, IVIG, heart failure, and biologic therapies to patients across 14 southeastern and mid-Atlantic U.S. states through hospital partnerships, home visits, and six infusion centers.
- Ownership category
- akta.pro rank
ContinuumRx industry classification
Industry- Product category
- Home Infusion Therapy and Specialty Pharmacy Services
- NAICS
- Home Health Care Services (621610)
- SIC
- Services-Home Health Care Services (8082)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Home Infusion Therapy Providers (HLAFAEAE), Injectables & Specialty Medication Support (e.g., insulin, biologics) (HSABALAG), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)
Keywords
Where ContinuumRx is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
ContinuumRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Specialty Pharmacy and Infusion Services: ContinuumRx generates revenue through providing home and site-based infusion therapies billed to commercial insurance, Medicare Part B, and Medicaid. Services include antibiotic therapy, parenteral/enteral nutrition, IVIG, heart failure therapy, and biologic therapies. Commercial insurers typically reimburse at 40-60% less than hospital costs. The company recently became in-network with United Healthcare and accepts nearly all insurance carriers including state Medicaid for out-of-state patients in emergencies.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
ContinuumRx product offering
Product offeringCore offering
ContinuumRx delivers home and site-based infusion therapy and specialty pharmacy services to patients requiring complex IV treatments, partnering with health systems to coordinate post-acute care. Core clinical offerings include IV antibiotic therapy, enteral and parenteral nutrition, IVIG, heart failure inotropic therapy, and biologic/specialty medications, supported by clinical nursing, sterile compounding, durable medical equipment, and 24/7 on-call coverage across 14 southeastern and mid-Atlantic U.S. states.
Product overview
ContinuumRx is a specialty pharmacy and home infusion services provider offering a unified portfolio of clinical care services. The core offerings include Antibiotic Therapy, Enteral Nutrition (tube feeding), Parenteral Nutrition (TPN), IVIG Therapy, Heart Failure Therapy, and Biologic Therapies. These services are delivered through home infusion and alternate site-based infusion suites, supported by patient education materials and medical devices like the Elastomeric Infusion Device. The company serves patients throughout the Greater Southeastern U.S. with infusion centers in Alabama, Tennessee, Virginia, and Ohio.
Differentiator
Problem solved
Functional benefit
Brands
- Continuum Health: Wholly-owned subsidiary providing full-service, relaxing infusion facilities with spa-like patient environment.
Products and services
- Antibiotic Therapy Home intravenous antibiotic therapy service that administers short- and long-term IV antibiotics, allowing patients to avoid unnecessary hospitalization.
- Enteral Nutrition
- Parenteral Nutrition (TPN)
- Immunoglobulin Therapy (IVIG)
- Heart Failure Therapy
- Biologic Therapies and Specialty Medications
- Continuum Health Infusion Facilities
Quantifiable outcome
- Home infusion saves $1,928 to $2,974 per treatment course compared to medical setting infusion costs
- +1 more outcomes
Companies that use ContinuumRx
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
ContinuumRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ContinuumRx partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- National HealthCare Corporation (NHC)coreCollaboration with NHC (NYSE: NHC) to provide COVID-19 bamlanivimab infusion treatments to high-risk patients in long-term care facilities. Partnership formed as part of NHIA pilot program with Operation Warp Speed. NHC operates nearly 100 nursing centers across 10 states.
- Ascension Saint ThomascoreMajor health system partnership providing integrated specialty infusion services and seamless patient transitions from hospital to home care settings.
- Ascension St. Vincent'scoreHealth system partnership for post-acute care coordination and home infusion services.
- The University of Tennessee Medical CentercoreAcademic medical center partnership providing integrated specialty infusion services.
- Erlanger Home InfusioncoreHome infusion partnership with regional health system for patient discharge and home care services.
- Huntsville Hospital Home InfusioncoreRegional hospital partnership for home infusion therapy coordination.
- InovacoreMajor health system partnership in Virginia region for integrated infusion services.
- UAB MedicinecoreAcademic health system partnership providing integrated specialty infusion and care coordination.
- Home Health AgenciesminorPartnership with home health agencies for IV and subcutaneous antibody therapy administration. Nurses from partner agencies provide continuity of care for trained patients.
- Acelpa HealthcoreContinuumRx is now an Acelpa Health company, operating as a subsidiary with shared leadership and branding.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
ContinuumRx competitors and assessment
Company assessmentDirect peers
- Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S., formed via the 2019 BioScrip merger. Directly comparable to ContinuumRx in core services (home infusion, specialty pharmacy, infusion suites), but operates at national scale.
- Soleo Health: Specialty infusion and home infusion provider focused on IVIG, biologics, and complex therapies. Highly comparable specialty drug portfolio and home/ambulatory delivery model.
- Amerita: Specialty infusion provider offering home and alternate-site IV therapy, including TPN, IVIG, and antibiotics. Comparable scale and service mix; operates as a privately held national platform.
- Vital Care Infusion Services: Franchise-based home and alternate-site infusion pharmacy network. Competes with ContinuumRx for the same patient population (IV antibiotics, biologics, nutrition support) with a regional-clinic delivery model.
- Pentec Health: Specialty infusion and nutrition provider, with particular strength in TPN and renal therapies. Comparable in clinical complexity and home-delivery model.
- KabaFusion: National home infusion provider specializing in IVIG, biologics, and acute/chronic infusion therapies. Closest mid-market private peer to ContinuumRx in service mix, clinical complexity, and specialty drug focus.
Broad incumbents
- Coram CVS Health (Coram): Home infusion and specialty pharmacy division of CVS Health. Offers the same core services as ContinuumRx (IVIG, antibiotics, TPN, biologics) but as part of a national retail/specialty pharmacy platform with much broader payer reach.
- BriovaRx (OptumRx): Specialty and home infusion pharmacy within OptumRx / UnitedHealth Group. Highly comparable service mix to ContinuumRx; competes for the same specialty drug referrals and benefits from United's payer scale.
Others
- NHIA (National Home Infusion Association): Industry association of which ContinuumRx is a member. Not a competitor, but the dominant trade body shaping home infusion accreditation, reimbursement policy, and clinical standards — directly relevant to ContinuumRx's regulatory environment.
Regional players
- Paragon Healthcare: Specialty infusion and home infusion provider concentrated in the U.S. Southwest. Comparable services (biologics, IVIG, antibiotics, TPN) but regional rather than Southeast-focused like ContinuumRx.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
ContinuumRx social profiles
Digital presenceContinuumRx compliance and trust
Trust signalCompliance4 records
ContinuumRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
ContinuumRx leadership team
Management profileNumber of profiles
Profiles13 records
ContinuumRx subsidiaries and ownership
Company hierarchySubsidiaries1 record
ContinuumRx funding detail
Funding detailFunding overview
Funding rounds2 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ContinuumRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ContinuumRx
What does ContinuumRx do?
ContinuumRx delivers home and site-based infusion therapy and specialty pharmacy services to patients requiring complex IV treatments, partnering with health systems to coordinate post-acute care. Core clinical offerings include IV antibiotic therapy, enteral and parenteral nutrition, IVIG, heart failure inotropic therapy, and biologic/specialty medications, supported by clinical nursing, sterile compounding, durable medical equipment, and 24/7 on-call coverage across 14 southeastern and mid-Atlantic U.S. states.
Is ContinuumRx a public or private company?
ContinuumRx is a private company. It is classified as corporate owned and is currently operating.
When was ContinuumRx founded?
ContinuumRx was founded in 2003. It employs 1 to 10 people.
Where is ContinuumRx based?
ContinuumRx is headquartered in Birmingham, United States, in the North America region.
How does ContinuumRx make money?
One revenue line is on record: specialty Pharmacy and Infusion Services.
Who are ContinuumRx's main competitors?
Direct peers on record are Option Care Health, Soleo Health, Amerita, Vital Care Infusion Services, Pentec Health and KabaFusion. Broad incumbents are Coram CVS Health (Coram) and BriovaRx (OptumRx). NHIA (National Home Infusion Association) is listed as an others. Paragon Healthcare is listed as a regional player.
Does ContinuumRx have an API?
No public API is recorded for ContinuumRx.
What industry is ContinuumRx in?
ContinuumRx's product category is Home Infusion Therapy and Specialty Pharmacy Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFAEAE, Home Infusion Therapy Providers. Its NAICS code is 621610 and its SIC code is 8082.